These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 31498806)
81. Efficacy of long-term repeated rituximab treatment in refractory phospholipase A2 receptor-antibody-related membranous nephropathy. Zhang L; Chen M; Le W; Zhang M; Tu Y; Zuo K; Chen D; Wu Y; Li S; Zeng C; Cheng Z; Xie H Immunotherapy; 2022 Oct; 14(15):1237-1244. PubMed ID: 36097696 [TBL] [Abstract][Full Text] [Related]
82. Pharmacological treatment of primary membranous nephropathy in 2016. van de Logt AE; Hofstra JM; Wetzels JF Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1463-1478. PubMed ID: 27535699 [TBL] [Abstract][Full Text] [Related]
83. Management of Membranous Nephropathy after MENTOR. Trivin-Avillach C; Beck LH Clin J Am Soc Nephrol; 2020 Mar; 15(3):415-417. PubMed ID: 31740571 [No Abstract] [Full Text] [Related]
84. Membranous nephropathy with crescents: a series of 19 cases. Rodriguez EF; Nasr SH; Larsen CP; Sethi S; Fidler ME; Cornell LD Am J Kidney Dis; 2014 Jul; 64(1):66-73. PubMed ID: 24709471 [TBL] [Abstract][Full Text] [Related]
85. Altered glycosylation of IgG4 promotes lectin complement pathway activation in anti-PLA2R1-associated membranous nephropathy. Haddad G; Lorenzen JM; Ma H; de Haan N; Seeger H; Zaghrini C; Brandt S; Kölling M; Wegmann U; Kiss B; Pál G; Gál P; Wüthrich RP; Wuhrer M; Beck LH; Salant DJ; Lambeau G; Kistler AD J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33351779 [TBL] [Abstract][Full Text] [Related]
86. A New Chemiluminescence Immunoassay for Phospholipase A Hoxha E; Stahl RAK; Reinhard L; Kühnl A; Schlumberger W; Dähnrich C Kidney Int Rep; 2021 Apr; 6(4):928-935. PubMed ID: 33912742 [TBL] [Abstract][Full Text] [Related]
87. Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy. Hihara K; Iyoda M; Tachibana S; Iseri K; Saito T; Yamamoto Y; Suzuki T; Wada Y; Matsumoto K; Shibata T PLoS One; 2016; 11(6):e0158154. PubMed ID: 27355365 [TBL] [Abstract][Full Text] [Related]
88. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy. Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981 [TBL] [Abstract][Full Text] [Related]
89. Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab. van de Logt AE; Dahan K; Rousseau A; van der Molen R; Debiec H; Ronco P; Wetzels J Kidney Int; 2018 Apr; 93(4):1016-1017. PubMed ID: 29571438 [No Abstract] [Full Text] [Related]
90. Circulating antibodies to α-enolase and phospholipase A Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547 [TBL] [Abstract][Full Text] [Related]
91. [Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update]. Pozdzik AA; Debiec H; I Brochériou ; Husson C; Rorive S; Broeders N; Le Moine A; Ronco P; Nortier J Rev Med Brux; 2015; 36(3):166-71. PubMed ID: 26372979 [TBL] [Abstract][Full Text] [Related]
92. [Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?]. Netti GS; Ranieri E G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030016 [TBL] [Abstract][Full Text] [Related]
93. Effects of hydroxychloroquine on proteinuria in membranous nephropathy. Cheng YJ; Cheng XY; Zhang YM; Wang F; Wang X; Meng LQ; Liu G; Cui Z; Zhao MH J Nephrol; 2022 May; 35(4):1145-1157. PubMed ID: 34846713 [TBL] [Abstract][Full Text] [Related]
94. Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial. Brglez V; Boyer-Suavet S; Zorzi K; Fernandez C; Fontas E; Esnault V; Seitz-Polski B Front Med (Lausanne); 2020; 7():412. PubMed ID: 32903623 [No Abstract] [Full Text] [Related]
95. [Detection of PLA2R1 in renal biopsy specimens of patients with idiopathic membranous nephropathy]. Zhu SS; Zhou SL; Zhou CM; Li YQ; Zou HQ Nan Fang Yi Ke Da Xue Xue Bao; 2015 Apr; 35(4):526-9. PubMed ID: 25907937 [TBL] [Abstract][Full Text] [Related]
96. Serum secretory phospholipase A2 group IB correlates with the severity of membranous nephropathy. Li W; Zhang M; Guo Y; Liu X; Ji X; Su J; Zhang Z; Zhang F Clin Chim Acta; 2018 Jul; 482():178-184. PubMed ID: 29649452 [TBL] [Abstract][Full Text] [Related]
97. Detection and clinical significance of glomerular M-type phospholipase A Liu H; Luo W; Gong S; Ding X Intern Med J; 2016 Nov; 46(11):1318-1322. PubMed ID: 27554390 [TBL] [Abstract][Full Text] [Related]
98. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Larsen CP; Messias NC; Silva FG; Messias E; Walker PD Mod Pathol; 2013 May; 26(5):709-15. PubMed ID: 23196797 [TBL] [Abstract][Full Text] [Related]
99. Introduction of a novel chimeric active immunization mouse model of PLA2R1-associated membranous nephropathy. Tomas NM; Schnarre A; Dehde S; Lucas R; Hermans-Borgmeyer I; Kretz O; Koellner SMS; Wiech T; Koch-Nolte F; Seifert L; Huber TB; Zahner G Kidney Int; 2023 Nov; 104(5):916-928. PubMed ID: 37598854 [TBL] [Abstract][Full Text] [Related]
100. Membranous nephropathy-one morphologic pattern with different diseases. Hoxha E; von Haxthausen F; Wiech T; Stahl RAK Pflugers Arch; 2017 Aug; 469(7-8):989-996. PubMed ID: 28555350 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]